- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06449807
Effects of Crossover Point Exercise on Depression, Anxiety and Stress in Chinese Postmenopausal Women
June 6, 2024 updated by: Beijing Sport University
To analyze the effects of the Crossover Point (COP) Exercise Program on Chinese postmenopausal women.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
This is a randomized clinical trial of single-blind with 2 arms (control group and experimental group), in which a pre-treatment-posttest design has been used.
Study Type
Interventional
Enrollment (Estimated)
80
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Peizhen Zhang
- Phone Number: 01062989581
- Email: zhpzh@bsu.edu.cn
Study Locations
-
-
-
Beijing, China
- Recruiting
- School of Sports Medicine and Rehabilitation, Beijing Sport University
-
Contact:
- Peizhen Zhang
- Email: zhpzh@bsu.edu.cn
-
Principal Investigator:
- Peizhen Zhang
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Postmenopausal women without incapacitating chronic disease or contraindications to exercise
- baseline mental health
- no severe chronic diseases or exercise contraindications
- ability to understand the research details and voluntarily sign the informed consent form.
Exclusion Criteria:
- Women with undetermined menopause;
- BMI <18.5 kg/m2 or BMI >28 kg/m2
- uncontrolled hypertension (systolic blood pressure >160 mmHg and/or diastolic blood pressure >110 mmHg)
- life-threatening illness with a prognosis of <5 years
- currently receiving estrogen therapy
- currently taking medication that may affect psychological testing
- contraindications to exercise
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: No Intervention
|
|
|
Active Comparator: crossover point intensity exercise
|
crossover point intensity exercise
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
DASS-21 (Depression Anxiety Stress Scale-21)
Time Frame: At the beginning-at three months.
|
The scale has 21 questions that cover a wide range of symptoms of depression, anxiety, and stress.
Each of the questions was stated in the first person, assertive tone, and required the participants to grade on a 4-point scale their experiences with a score of 0 (did not apply to me at all), 1 (applied to me to some degree or some of the time), 2 (applied to me to a considerable degree or a good part of the time), and 3 (applied to me very much or most of the time).
The higher value represents a worse result.
|
At the beginning-at three months.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Body Mass Index (BMI )
Time Frame: At the beginning-at three months.
|
Is calculated from the formula, Weight (kg) / Height2 (m2), whose unit is kg/m2.
It is a rough indicator of total body fat.
|
At the beginning-at three months.
|
|
Body Image States Scale (BISS)
Time Frame: At the beginning-at three months.
|
The BISS contains six items that assess different aspects of body image such as physical appearance, body size and shape, body weight, and attractiveness, as well as concerns about how one looks relative to others.
Participants were instructed to complete the questionnaire describing ''How are you feeling right now?''
A higher score represents higher body image satisfaction.
The BISS is an internally consistent scale, and construct validity has been confirmed.
|
At the beginning-at three months.
|
|
Body Appreciation Scale-2 (BAS-2)
Time Frame: At the beginning-at three months.
|
The BAS-2 used in this study is the version revised by Swami et al., it comprises a total of 10 items, scored using a Likert five-point scale, corresponding to the options "Never, Rarely, Sometimes, Often, Always," with each item scored from 1 to 5 points.
A higher score indicates a stronger appreciation of one's own body.
|
At the beginning-at three months.
|
|
The Meaning in Life Questionnaire (MLQ)
Time Frame: At the beginning-at three months.
|
A reliable, valid and practical screening tool for identifying and quantifying Meaning in Life.
|
At the beginning-at three months.
|
|
The Subjective Happiness Scale (SMS)
Time Frame: At the beginning-at three months.
|
Questionnaire that evaluates the subjective happiness.
|
At the beginning-at three months.
|
|
Body composition
Time Frame: At the beginning-at three months.
|
Body composition indicators analysis was assessed using DXA.
Body compositon indicators include: fat mass,lean body mass,percentage of body fat.
|
At the beginning-at three months.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 20, 2024
Primary Completion (Estimated)
September 30, 2024
Study Completion (Estimated)
December 31, 2024
Study Registration Dates
First Submitted
February 21, 2024
First Submitted That Met QC Criteria
June 6, 2024
First Posted (Actual)
June 10, 2024
Study Record Updates
Last Update Posted (Actual)
June 10, 2024
Last Update Submitted That Met QC Criteria
June 6, 2024
Last Verified
February 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ECPEDASCPW
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.